← Open Payments lookup

KACI DEVILLIER: Open Payments

NPI 1477165132 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 25 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $202 · 2025 $541

Food & beverage: $541
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$245
ABBVIE INC.4$83
Vanda Pharmaceuticals Inc.2$38
Braeburn Inc.2$38
Janssen Pharmaceuticals, Inc1$23
Axsome Therapeutics, Inc.1$22
E.R. Squibb & Sons, L.L.C.1$22
Teva Pharmaceuticals USA, Inc.1$21
Lundbeck LLC1$19
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: CAPLYTA, VRAYLAR, BRIXADI, SPRAVATO, Auvelity, COBENFY, UZEDY, HETLIOZ.

Industry payments across LA — which companies pay providers there.